{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T04:55:16Z","timestamp":1782968116547,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82400677"],"award-info":[{"award-number":["82400677"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82130018"],"award-info":[{"award-number":["82130018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"the China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2024M752176"],"award-info":[{"award-number":["2024M752176"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Beijing Natural Science Foundation of China","award":["7242042"],"award-info":[{"award-number":["7242042"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-02755-w","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T12:27:43Z","timestamp":1771849663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Activation of aryl hydrocarbon receptor alleviates cholestatic liver injury by inhibiting inflammation"],"prefix":"10.1186","volume":"24","author":[{"given":"Qi","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Likai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuzhen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"2755_CR1","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.biopha.2017.02.084","volume":"89","author":"HQ Zhou","year":"2017","unstructured":"Zhou HQ, Liu W, Wang J, Huang YQ, Li PY, Zhu Y, Wang JB, Ma X, Li RS, Wei SZ, et al. Paeoniflorin attenuates ANIT-induced cholestasis by inhibiting apoptosis in vivo via mitochondria-dependent pathway. Biomed Pharmacother. 2017;89:696\u2013704.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"2755_CR2","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1038\/s41401-018-0110-y","volume":"39","author":"SY Wu","year":"2018","unstructured":"Wu SY, Cui SC, Wang L, Zhang YT, Yan XX, Lu HL, Xing GZ, Ren J, Gong LK. 18beta-Glycyrrhetinic acid protects against alpha-naphthylisothiocyanate-induced cholestasis through activation of the Sirt1\/FXR signaling pathway. Acta Pharmacol Sin. 2018;39(12):1865\u201373.","journal-title":"Acta Pharmacol Sin"},{"issue":"12","key":"2755_CR3","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1111\/apt.14678","volume":"47","author":"K Ashby","year":"2018","unstructured":"Ashby K, Navarro AE, Tong W, Borlak J, Mehta R, Chen M. Review article: therapeutic bile acids and the risks for hepatotoxicity. Aliment Pharmacol Ther. 2018;47(12):1623\u201338.","journal-title":"Aliment Pharmacol Ther"},{"key":"2755_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jep.2016.08.049","volume":"194","author":"X Tang","year":"2016","unstructured":"Tang X, Yang Q, Yang F, Gong J, Han H, Yang L, Wang Z. Target profiling analyses of bile acids in the evaluation of hepatoprotective effect of gentiopicroside on ANIT-induced cholestatic liver injury in mice. J Ethnopharmacol. 2016;194:63\u201371.","journal-title":"J Ethnopharmacol"},{"issue":"Suppl 1","key":"2755_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/liv.13306","volume":"37","author":"E de Vries","year":"2017","unstructured":"de Vries E, Beuers U. Management of cholestatic disease in 2017. Liver Int. 2017;37(Suppl 1):123\u20139.","journal-title":"Liver Int"},{"key":"2755_CR6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bbrc.2022.07.030","volume":"623","author":"P Kang","year":"2022","unstructured":"Kang P, Li S. Makisterone A attenuates experimental cholestasis by activating the farnesoid X receptor. Biochem Biophys Res Commun. 2022;623:162\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"2755_CR7","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jhep.2023.12.023","volume":"80","author":"TS Andrews","year":"2024","unstructured":"Andrews TS, Nakib D, Perciani CT, Ma XZ, Liu L, Winter E, Camat D, Chung SW, Lumanto P, Manuel J, et al. Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver. J Hepatol. 2024;80(5):730\u201343.","journal-title":"J Hepatol"},{"issue":"4","key":"2755_CR8","first-page":"346","volume":"32","author":"MM Tiao","year":"2009","unstructured":"Tiao MM, Lin TK, Wang PW, Chen JB, Liou CW. The role of mitochondria in cholestatic liver injury. Chang Gung Med J. 2009;32(4):346\u201353.","journal-title":"Chang Gung Med J"},{"issue":"11","key":"2755_CR9","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1007\/s11010-023-04682-7","volume":"478","author":"Y Tan","year":"2023","unstructured":"Tan Y, Zhao N, Xie Q, Xu Z, Chai J, Zhang X, Li Y. Melatonin attenuates cholestatic liver injury via inhibition of the inflammatory response. Mol Cell Biochem. 2023;478(11):2527\u201337.","journal-title":"Mol Cell Biochem"},{"key":"2755_CR10","doi-asserted-by":"publisher","first-page":"100292","DOI":"10.1016\/j.prmcm.2023.100292","volume":"8","author":"J Hao","year":"2023","unstructured":"Hao J, Shen X, Lu K, Xu Y, Chen Y, Liu J, Shao X, Zhu C, Ding Y, Xie X, et al. Scoparone attenuates cholestatic liver injury through regulating hepatic bile acid metabolism, ameliorating periductal fibrosis and inhibiting inflammatory response. Pharmacol Res - Mod Chin Med. 2023;8:100292.","journal-title":"Pharmacol Res - Mod Chin Med"},{"issue":"8","key":"2755_CR11","doi-asserted-by":"publisher","first-page":"104968","DOI":"10.1016\/j.arabjc.2023.104968","volume":"16","author":"J Hao","year":"2023","unstructured":"Hao J, Shen X, Shao X, Zhu C, Lu K, Xu Y, Chen Y, Liu J, Ding Y, Xie X, et al. Honokiol attenuates ductular reaction, regulates of bile acids metabolism, and inhibits inflammatory response in murine cholestatic liver injury model. Arab J Chem. 2023;16(8):104968.","journal-title":"Arab J Chem"},{"issue":"1","key":"2755_CR12","doi-asserted-by":"publisher","first-page":"e12929","DOI":"10.1111\/jpi.12929","volume":"76","author":"X Liu","year":"2024","unstructured":"Liu X, Li J, Shi M, Fu J, Wang Y, Kang W, Liu J, Zhu F, Huang K, Chen X, Liu Y. Melatonin improves cholestatic liver disease via the gut-liver axis. J Pineal Res. 2024;76(1):e12929.","journal-title":"J Pineal Res"},{"issue":"12","key":"2755_CR13","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1111\/bph.15429","volume":"178","author":"J Xiang","year":"2021","unstructured":"Xiang J, Yang G, Ma C, Wei L, Wu H, Zhang W, Tao X, Jiang L, Liang Z, Kang L, Yang S. Tectorigenin alleviates intrahepatic cholestasis by inhibiting hepatic inflammation and bile accumulation via activation of PPARgamma. Br J Pharmacol. 2021;178(12):2443\u201360.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"2755_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.abb.2010.09.001","volume":"504","author":"Y Kawano","year":"2010","unstructured":"Kawano Y, Nishiumi S, Tanaka S, Nobutani K, Miki A, Yano Y, Seo Y, Kutsumi H, Ashida H, Azuma T, Yoshida M. Activation of the aryl hydrocarbon receptor induces hepatic steatosis via the upregulation of fatty acid transport. Arch Biochem Biophys. 2010;504(2):221\u20137.","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"2755_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/hep.28518","volume":"64","author":"L Yao","year":"2016","unstructured":"Yao L, Wang C, Zhang X, Peng L, Liu W, Zhang X, Liu Y, He J, Jiang C, Ai D, Zhu Y. Hyperhomocysteinemia activates the aryl hydrocarbon receptor\/CD36 pathway to promote hepatic steatosis in mice. Hepatology. 2016;64(1):92\u2013105.","journal-title":"Hepatology"},{"key":"2755_CR16","doi-asserted-by":"publisher","first-page":"105180","DOI":"10.1016\/j.phrs.2020.105180","volume":"160","author":"Y Shi","year":"2020","unstructured":"Shi Y, Zeng Z, Yu J, Tang B, Tang R, Xiao R. The aryl hydrocarbon receptor: An environmental effector in the pathogenesis of fibrosis. Pharmacol Res. 2020;160:105180.","journal-title":"Pharmacol Res"},{"key":"2755_CR17","doi-asserted-by":"publisher","first-page":"106057","DOI":"10.1016\/j.phrs.2022.106057","volume":"176","author":"J Liu","year":"2022","unstructured":"Liu J, Pi Z, Xiao Y, Zeng Z, Yu J, Zou P, Tang B, Qiu X, Tang R, Shi Y, Xiao R. Esomeprazole alleviates fibrosis in systemic sclerosis by modulating AhR\/Smad2\/3 signaling. Pharmacol Res. 2022;176:106057.","journal-title":"Pharmacol Res"},{"issue":"3","key":"2755_CR18","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1053\/j.gastro.2019.05.066","volume":"157","author":"J Yan","year":"2019","unstructured":"Yan J, Tung HC, Li S, Niu Y, Garbacz WG, Lu P, Bi Y, Li Y, He J, Xu M, et al. Aryl Hydrocarbon Receptor Signaling Prevents Activation of Hepatic Stellate Cells and Liver Fibrogenesis in Mice. Gastroenterology. 2019;157(3):793\u2013e80614.","journal-title":"Gastroenterology"},{"key":"2755_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.bbrc.2023.10.030","volume":"682","author":"Q Han","year":"2023","unstructured":"Han Q, Yan X, Wang L, Zhang N, Zhang W, Li H, Chen W, You H, Yang A. Aryl hydrocarbon receptor attenuates cholestatic liver injury by regulating bile acid metabolism. Biochem Biophys Res Commun. 2023;682:259\u201365.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2755_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3892\/ijmm.2016.2825","volume":"39","author":"X Zhang","year":"2017","unstructured":"Zhang X, Lu J, He B, Tang L, Liu X, Zhu D, Cao H, Wang Y, Li L. A tryptophan derivative, ITE, enhances liver cell metabolic functions in vitro. Int J Mol Med. 2017;39(1):101\u201312.","journal-title":"Int J Mol Med"},{"key":"2755_CR21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/978-1-4939-9420-5_16","volume":"1981","author":"E Pose","year":"2019","unstructured":"Pose E, Sancho-Bru P, Coll M. 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine Diet: A Rodent Model in Cholestasis Research. Methods Mol biology (Clifton N J). 2019;1981:249\u201357.","journal-title":"Methods Mol biology (Clifton N J)"},{"issue":"15","key":"2755_CR22","doi-asserted-by":"publisher","first-page":"4108","DOI":"10.7150\/ijbs.64894","volume":"17","author":"Q Han","year":"2021","unstructured":"Han Q, Chen H, Wang L, An Y, Hu X, Zhao Y, Zhang H, Zhang R. Systemic Deficiency of GHR in Pigs leads to Hepatic Steatosis via Negative Regulation of AHR Signaling. Int J Biol Sci. 2021;17(15):4108\u201321.","journal-title":"Int J Biol Sci"},{"key":"2755_CR23","doi-asserted-by":"crossref","unstructured":"Lopez-Montoya P, Cerqueda-Garcia D, Rodriguez-Flores M, Lopez-Contreras B, Villamil-Ramirez H, Moran-Ramos S, Molina-Cruz S, Rivera-Paredez B, Antuna-Puente B, Velazquez-Cruz R et al. Association of Gut Microbiota with Atherogenic Dyslipidemia, and Its Impact on Serum Lipid Levels after Bariatric Surgery. Nutrients. 2022; 14(17):3545.","DOI":"10.3390\/nu14173545"},{"issue":"3","key":"2755_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s12276-022-00737-9","volume":"54","author":"D Han","year":"2022","unstructured":"Han D, Kim H, Kim S, Le QA, Han SY, Bae J, Shin HW, Kang HG, Han KH, Shin J, Park HW. Sestrin2 protects against cholestatic liver injury by inhibiting endoplasmic reticulum stress and NLRP3 inflammasome-mediated pyroptosis. Exp Mol Med. 2022;54(3):239\u201351.","journal-title":"Exp Mol Med"},{"key":"2755_CR25","doi-asserted-by":"crossref","unstructured":"Chen L, Wei S, Liu H, Li J, Jing M, Tong Y, Li R, Wen J, Zhan H, Zhao Y. Paeoniflorin Protects against ANIT-Induced Cholestatic Liver Injury in Rats via the Activation of SIRT1-FXR Signaling Pathway. Evid Based Complement Alternat Med. 2021; 2021:8479868.","DOI":"10.1155\/2021\/8479868"},{"issue":"5","key":"2755_CR26","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/s41588-024-01687-w","volume":"56","author":"B Wu","year":"2024","unstructured":"Wu B, Shentu X, Nan H, Guo P, Hao S, Xu J, Shangguan S, Cui L, Cen J, Deng Q, et al. A spatiotemporal atlas of cholestatic injury and repair in mice. Nat Genet. 2024;56(5):938\u201352.","journal-title":"Nat Genet"},{"issue":"11","key":"2755_CR27","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.7150\/thno.95749","volume":"14","author":"Y Gao","year":"2024","unstructured":"Gao Y, Liu K, Xiao W, Xie X, Liang Q, Tu Z, Yang L, Yu H, Guo H, Huang S, et al. Aryl hydrocarbon receptor confers protection against macrophage pyroptosis and intestinal inflammation through regulating polyamine biosynthesis. Theranostics. 2024;14(11):4218\u201339.","journal-title":"Theranostics"},{"issue":"4","key":"2755_CR28","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00281-021-00867-8","volume":"43","author":"A Carambia","year":"2021","unstructured":"Carambia A, Schuran FA. The aryl hydrocarbon receptor in liver inflammation. Semin Immunopathol. 2021;43(4):563\u201375.","journal-title":"Semin Immunopathol"},{"issue":"1","key":"2755_CR29","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1146\/annurev-immunol-032713-120245","volume":"32","author":"B Stockinger","year":"2014","unstructured":"Stockinger B, Di Meglio P, Gialitakis M, Duarte JH. The Aryl Hydrocarbon Receptor: Multitasking in the Immune System. Annu Rev Immunol. 2014;32(1):403\u201332.","journal-title":"Annu Rev Immunol"},{"key":"2755_CR30","doi-asserted-by":"crossref","unstructured":"Neavin DR, Liu D, Ray B, Weinshilboum RM. The Role of the Aryl Hydrocarbon Receptor (AHR) in Immune and Inflammatory Diseases. Int J Mol Sci. 2018; 19(12):3851.","DOI":"10.3390\/ijms19123851"},{"issue":"1","key":"2755_CR31","first-page":"39","volume":"25","author":"P Sharma","year":"2010","unstructured":"Sharma P, Kaur J, Sanyal SN. Effect of etoricoxib, a cyclooxygenase-2 selective inhibitor on aberrant crypt formation and apoptosis in 1,2 dimethyl hydrazine induced colon carcinogenesis in rat model. Nutr Hosp. 2010;25(1):39\u201348.","journal-title":"Nutr Hosp"},{"issue":"3","key":"2755_CR32","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1089\/ars.2009.2903","volume":"13","author":"K Kawata","year":"2010","unstructured":"Kawata K, Kobayashi Y, Souda K, Kawamura K, Sumiyoshi S, Takahashi Y, Noritake H, Watanabe S, Suehiro T, Nakamura H. Enhanced hepatic Nrf2 activation after ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. Antioxid Redox Signal. 2010;13(3):259\u201368.","journal-title":"Antioxid Redox Signal"},{"key":"2755_CR33","doi-asserted-by":"publisher","first-page":"111678","DOI":"10.1016\/j.mce.2022.111678","volume":"552","author":"K Panzitt","year":"2022","unstructured":"Panzitt K, Zollner G, Marschall HU, Wagner M. Recent advances on FXR-targeting therapeutics. Mol Cell Endocrinol. 2022;552:111678.","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"2755_CR34","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1517\/14728222.10.3.409","volume":"10","author":"SY Cai","year":"2006","unstructured":"Cai SY, Boyer JL. FXR: a target for cholestatic syndromes? Expert Opin Ther Targets. 2006;10(3):409\u201321.","journal-title":"Expert Opin Ther Targets"},{"issue":"4","key":"2755_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.phrs.2010.12.018","volume":"63","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, Li F, Guo GL. Tissue-specific function of farnesoid X receptor in liver and intestine. Pharmacol Res. 2011;63(4):259\u201365.","journal-title":"Pharmacol Res"},{"issue":"1","key":"2755_CR36","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","volume":"71","author":"M Trauner","year":"2022","unstructured":"Trauner M, Fuchs CD. Novel therapeutic targets for cholestatic and fatty liver disease. Gut. 2022;71(1):194\u2013209.","journal-title":"Gut"},{"key":"2755_CR37","doi-asserted-by":"publisher","first-page":"154728","DOI":"10.1016\/j.metabol.2021.154728","volume":"118","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Du Z, Liu Q, Wu T, Tang Q, Zhang J, Huang C, Huang Y, Li R, Li Y, et al. Glucagon-like peptide 1 analogue prevents cholesterol gallstone formation by modulating intestinal farnesoid X receptor activity. Metabolism. 2021;118:154728.","journal-title":"Metabolism"},{"issue":"1","key":"2755_CR38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/gerona\/glac148","volume":"78","author":"S Ha","year":"2023","unstructured":"Ha S, Yang Y, Won KJ, Son M, Kim D, Kim MJ, Im DS, Young CH, Chung KW. Diminished Tubule Epithelial Farnesoid X Receptor Expression Exacerbates Inflammation and Fibrosis Response in Aged Rat Kidney. J Gerontol Biol Sci Med Sci. 2023;78(1):60\u20138.","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"1","key":"2755_CR39","first-page":"199","volume":"11","author":"F Zhou","year":"2019","unstructured":"Zhou F, Wang M, Ju J, Wang Y, Liu Z, Zhao X, Yan Y, Yan S, Luo X, Fang Y. Schizandrin A protects against cerebral ischemia-reperfusion injury by suppressing inflammation and oxidative stress and regulating the AMPK\/Nrf2 pathway regulation. Am J Transl Res. 2019;11(1):199\u2013209.","journal-title":"Am J Transl Res"},{"issue":"6","key":"2755_CR40","first-page":"377","volume":"3","author":"V Bieghs","year":"2014","unstructured":"Bieghs V, Trautwein C. Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease. Hepatobiliary Surg Nutr. 2014;3(6):377\u201385.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"4","key":"2755_CR41","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s43440-019-00043-8","volume":"72","author":"M Dai","year":"2020","unstructured":"Dai M, Yang J, Luo Y, Xu L, Zhang H, Xu G, Liu A. Therapeutic action against chronic cholestatic liver injury by low-dose fenofibrate involves anti-chemotaxis via JNK-AP1-CCL2\/CXCL2 signaling. Pharmacol Rep. 2020;72(4):935\u201344.","journal-title":"Pharmacol Rep"},{"issue":"4","key":"2755_CR42","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00383-011-2974-5","volume":"28","author":"T Asakawa","year":"2012","unstructured":"Asakawa T, Yagi M, Tanaka Y, Asagiri K, Kobayashi H, Egami H, Tanikawa K, Kage M. The herbal medicine Inchinko-to reduces hepatic fibrosis in cholestatic rats. Pediatr Surg Int. 2012;28(4):379\u201384.","journal-title":"Pediatr Surg Int"},{"issue":"6","key":"2755_CR43","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/liv.13698","volume":"38","author":"D Yu","year":"2018","unstructured":"Yu D, Cai SY, Mennone A, Vig P, Boyer JL. Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents. Liver Int. 2018;38(6):1128\u201338.","journal-title":"Liver Int"},{"issue":"6","key":"2755_CR44","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","volume":"23","author":"A Agus","year":"2018","unstructured":"Agus A, Planchais J, Sokol H. Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host Microbe. 2018;23(6):716\u201324.","journal-title":"Cell Host Microbe"},{"key":"2755_CR45","doi-asserted-by":"crossref","unstructured":"Li H, Liang J, Han M, Gao Z. Polyphenols synergistic drugs to ameliorate non-alcoholic fatty liver disease via signal pathway and gut microbiota: A review. J Adv Res. 2025;68:43\u201362.","DOI":"10.1016\/j.jare.2024.03.004"},{"key":"2755_CR46","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jad.2024.05.150","volume":"360","author":"Q Huang","year":"2024","unstructured":"Huang Q, Liu L, Tan X, Wang S, Wang S, Luo J, Chen J, Yang N, Jiang J, Liu Y, et al. Empagliflozin alleviates neuroinflammation by inhibiting astrocyte activation in the brain and regulating gut microbiota of high-fat diet mice. J Affect Disord. 2024;360:229\u201341.","journal-title":"J Affect Disord"},{"key":"2755_CR47","doi-asserted-by":"publisher","first-page":"138916","DOI":"10.1016\/j.foodchem.2024.138916","volume":"447","author":"H Zeng","year":"2024","unstructured":"Zeng H, Liu C, Wan L, Peng L, Wen S, Fang W, Chen H, Wang K, Yang X, Huang J, Liu Z. (-)-Epicatechin ameliorates type 2 diabetes mellitus by reshaping the gut microbiota and Gut-Liver axis in GK rats. Food Chem. 2024;447:138916.","journal-title":"Food Chem"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02755-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02755-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02755-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T15:03:44Z","timestamp":1774623824000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02755-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2755"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02755-w","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"202"}}